Ribbon Bio

Vienna, Austria

Ribbon Bio defines new standards for molecular biology by applying innovative methods for DNA synthesis.

$20.2M raised

Jan 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ribbon Bio raised?

Ribbon Bio has raised $20.2M in total funding. The most recent round was Series A. The last funding was announced in January 2022.

Who are Ribbon Bio's investors?

Ribbon Bio's investors include Hadean Ventures, XISTA Science Ventures, tecnet equity, Lansdowne Partners, Helicase Venture.

Where is Ribbon Bio headquartered?

Ribbon Bio is headquartered in Vienna, Austria.

What does Ribbon Bio do?

Ribbon Bio defines new standards for molecular biology by applying innovative methods for DNA synthesis.

What stage is Ribbon Bio at?

Ribbon Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 31, 2022.

MLA

"Ribbon Bio — Funding & Investors." VCBacked, January 31, 2022, https://www.vcbacked.co/company/ribbon-bio. Accessed July 2, 2026.

APA

VCBacked. (2022). Ribbon Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ribbon-bio

Wikipedia (cite web)

{{cite web |title=Ribbon Bio — Funding & Investors |url=https://www.vcbacked.co/company/ribbon-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 31, 2022.